ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag stem cell trials microbiology evolution

Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Week in Review, July 15–19
Jef Akst | Jul 19, 2013 | 5 min read
Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation
tazmanian devils fighting cancer
Some Cancers Become Contagious
Katarina Zimmer | Apr 1, 2019 | 10+ min read
So far, six animal species are known to carry transmissible, “parasitic” forms of cancer, but researchers are still mystified as to how cancer can become infectious.
The Biggest Stories in Bioscience 2005
Ishani Ganguli | Dec 4, 2005 | 8 min read
Life scientists have been challenged more than ever this year not just to critically analyze data, but to better interpret those data for an increasingly critical public.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Top 10 Innovations 2012
The Scientist | Dec 1, 2012 | 10+ min read
The Scientist’s 5th installment of its annual competition attracted submissions from across the life science spectrum. Here are the best and brightest products of the year.
A Push and a Pull for PARP-1 in Aging
Jack Lucentini(jlucentini@the-scientist.com) | Aug 1, 2005 | 6 min read
Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.
Research Notes
Eugene Russo | Jun 25, 2000 | 5 min read
Putting Polio to Good Use Add polio to a host of other viral and bacterial foes that, in modified forms, could prove therapeutically beneficial. Although Russian scientists attempted to use polio to treat cancer in the 1960s--unpublished experiments about which little is known--a recent brain cancer study in mice is the first modern-day attempt to harness the power of the virus (M. Gromeier et al., "Intergeneric poliovirus recombinants for the treatment of malignant glioma," Proceedings of the
An 'Iterative Process'
Billy Goodman | Jul 9, 1995 | 7 min read
Sidebar: The AIDS Research Evaluators The 100-plus members of a newly constituted National Institutes of Health task force have begun their daunting task: a comprehensive reevaluation of NIH's entire $1.4 billion AIDS portfolio, including both intramural and extramural research. Compounding the challenge for the scientists and AIDS activists who make up the task force is a withering schedule. They will have to produce a report due in January 1996, to aid in planning the 1998 Office of AIDS Rese

Run a Search

ADVERTISEMENT